&
Effective Aerosol Therapy is the Best Tool to treat Pulmonary Disease
“A mesh nebulizer (Aerogen) is more effective than jet nebulizer to nebulize bronchodilators during non-invasive ventilation of subjects with COPD”
Aerogen Pro-X
“Although aerosol therapy is a mainstay procedure used in the treatment of pulmonary diseases in healthcare settings, it has potential for fugitive Covid emissions during therapy due to the generation of aerosols and droplets as a source of respiratory pathogens. Fugitive is defined as aerosols that have been released from the aerosol device during patient expiration. A closed system (Aerogen) is preferred in the treatment of Post Covid COPD patients”
CDC & NIH: Respir Med: July 19th 2020
TARGETED RESPIRATORY MEDICATION MANAGEMENT
Aerogen Solo
High Performance Aerosol Drug Delivery
6 Times MORE medication delivered to
lungs compared to a Jet Nebulizer
The Problem: Traditional Jet Nebulizers
2. MacIntyre, NR. Et al. (1985) 3. Dunne & Shortt (2018) 4. Cushen, B. et al (2016) 5. Gardenhire, DS. Et al (2013) 6. AARC (2003) 7. Dalal, AA. Et al (2011) 8. Dalal, AA. Et al (2010)
SNF On-Site Targeted Medication Program
2. MacIntyre, NR. Et al (1985) 10. Dugernier, J. et al (2016) 12. Aerogen Solo Instruction Manual
The Solution: 10-15% medication to the lungs
High Performance Aerosol Across Multiple Modalities
10. Dugernier, J. et al (2016) 11. Dugernier J, et al. (2017) 13. Galindo-Filho VC, et al. (2015)
The Solution: Potential Reduced Risk of Infection
5. Gardenhire, D. et al (2013) 12. Aerogen Solo Instruction Manual
Targeted Respiratory Medication Management
Traditional Nebulizers used in SNF’s provide only “large micron” nebulization which results in the majority of prescribed medication being “washed out” in upper airway or ineffective Rx
IPS uses Aerogen High Output Nebulizers providing smaller Micron delivery resulting in 6 times more medication being delivered to the patient per physician order
IPS focused Respiratory Medication Program identifies patients who are at “high-risk” for
re-admission and
qualifies those patients within the Skilled Nursing Facility for treatment
IPS then completes post-aerosol therapy with aggressive Pulmonary follow up (i.e. Cough & Deep Breathing) to increase patient mobility and improve patient outcomes
IPS Program reduces nursing labor as a result of less nursing time being spent dealing with on-going respiratory issues including possible Covid-19 reinfections
IPS Program can also reduce costly hospital
re-admissions and provide
a marketing differential to referral sources who are looking for specialized RT which can result in new admissions.